Notable Labs, Inc.
News
Notable Labs to Present Data on September 4th at SOHO 2024
Globe Newswire Society of Hematologic Oncology (SOHO) session to highlight volasertib program Phase 2 volasertib AML program expected to begin in the coming months FOSTER CITY, Calif...\n more…
Notable Labs (NASDAQ:NTBL) Trading 2.4% Higher
Ticker Report Notable Labs, Ltd. (NASDAQ:NTBL - Get Free Report) traded up 2.4% during mid-day trading on Wednesday . The company traded as high as $0.64 and last traded at $0.64. 89,656 shares traded hands during...\n more…
Notable Labs CEO steps down
Seeking Alpha - Healthcare Notable Labs CEO steps down...\n more…
NTBL Stock Earnings: Notable Labs Misses EPS for Q2 2024
InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nNTBL stock results show that Notable Labs missed analyst estimates for earnings per share the second quarter of 2024.\nThe post NTBL...\n more…
Notable Labs (NASDAQ:NTBL) Trading 9.9% Higher
Ticker Report Notable Labs, Ltd. (NASDAQ:NTBL - Get Free Report)'s stock price traded up 9.9% during trading on Tuesday . The stock traded as high as $0.55 and last traded at $0.52. 48,172 shares were traded...\n more…
Notable Labs receives FDA clearance to proceed with Volasertib phase 2 study
SeekingAlpha.com: All News Notable Labs (NTBL) announces progress on Phase 2 volasertib program with FDA clearance and dosing plan agreement.\n more…